AI agents to accelerate clinical development workflows for the pharma industry.
Octozi has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Octozi's investors include Surface Ventures, (ERA) Entrepreneurs Roundtable Accelerator, Remarkable Ventures, DayOne accelerator, Debiopharm Innovation Fund.
Octozi is headquartered in New York, United States.
AI agents to accelerate clinical development workflows for the pharma industry.
Octozi is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Octozi — Funding & Investors." VCBacked, July 7, 2026, https://www.vcbacked.co/company/octozi. Accessed August 1, 2026.
VCBacked. (2026). Octozi — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/octozi
{{cite web |title=Octozi — Funding & Investors |url=https://www.vcbacked.co/company/octozi |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated